Trial Profile
Phase I Feasibility Study of Hexvix Photodynamic Therapy in Patients With Intermediate or High-risk Bladder Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- Sponsors PhotoCure
- 04 Mar 2011 New trial record